Elicit

AI for scientific research

Oakland, United States · Founded 2021 · $31.0M raised

Employees
11–50
Founded
2021
Business Model
B2B
Website
elicit.com
Total Funding
$31.0M
Last Round
$22.0M Series AFeb 2025
Rounds
2

About

Elicit is an AI-powered research platform trusted by over 5 million researchers worldwide. It helps researchers be 10x more evidence-based by automating time-consuming research tasks such as searching academic papers, extracting data, summarizing findings, and generating structured research reports. Elicit provides access to over 138 million academic papers and 545,000 clinical trials, with semantic search that surfaces relevant results without requiring exact keywords. Key workflows include systematic literature reviews (with up to 80% reported time savings), customizable research briefs, and automated data extraction validated at 99.4% accuracy across 1,500+ data points. Customers include pharmaceutical companies, academic institutions, medical device firms, and government policy teams.

Summary

Elicit is an Artificial Intelligence company based in Oakland, United States, founded in 2021. It has raised $31.0M in total across 2 rounds, most recently a $22.0M Series A round in Feb 2025. Investors include Fifty Years, Spark Capital and Footwork.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series ASeries AFeb 2025
$22.0M

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies